Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | CTSS | P25774 | 4/20 | 0.53 |
| ▸ | CTSK | P43235 | 3/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | KLK5 | Q9Y337 | 3/20 | 0.53 |
| ▸ | APP | P05067 | 5/20 | 0.51 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.48 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.48 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.48 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.48 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.48 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8910000 | 1.00 | ATM (0.61) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL8909987 | 1.00 | ATM (0.61) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL7347831 | 1.00 | ATM (0.61) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL22305235 | 1.00 | ATM (0.61) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL31506428 | 1.00 | ATM (0.61) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL2059435 | 1.00 | ATM (0.61) | ATMCTSSCTSKCTSLCTSB | |
| Oxalic Acid SCHEMBL7207478 | 0.98 | ATM (0.59) | ATMCTSSCTSKCTSLCTSB | |
| Oxalic Acid SCHEMBL8716603 | 0.98 | ATM (0.59) | ATMCTSSCTSKCTSLCTSB | |
| Malonic Acid SCHEMBL8710814 | 0.96 | ATM (0.58) | ATMCTSSCTSKCTSLCTSB | |
| Oxalic Acid SCHEMBL7211894 | 0.96 | ATM (0.58) | ATMCTSSCTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6667404-B2 | Carbamylation of 1-amino group of 1,4-amino-3-hydroxybutane derivative with an organocarbonate containing thiazolyl, oxazolyl, isoxazolyl or isothiazolyl substituent | ABBOTT LABORATORIES | 2003-12-23 | — | — | US | claimed |
| CN-112546969-A | Catalytic hydrogenation continuous production device and preparation method of ritonavir intermediate | 安徽贝克联合制药有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-111393329-A | Preparation method of ritonavir and lopinavir intermediate | 安徽一帆香料有限公司 | 2020-07-10 | — | — | CN | disclosed |
| CN-102180812-B | New method for industrial production of (2S,3S,5S)-2-amino-3-hydroxyl-5-tert-butyloxycarbonylamino-1,6-diphenyl hexane | JINAN AISI CHEMICAL CO LTD | 2013-06-19 | — | — | CN | disclosed |
| CN-102180812-B | New method for industrial production of (2S,3S,5S)-2-amino-3-hydroxyl-5-tert-butyloxycarbonylamino-1,6-diphenyl hexane | JINAN AISI CHEMICAL CO LTD | 2013-06-19 | — | — | CN | disclosed |
| CN-102180812-A | New method for industrial production of (2S,3S,5S)-2-amino-3-hydroxyl-5-tert-butyloxycarbonylamino-1,6-diphenyl hexane | JINAN AISI CHEMICAL CO LTD | 2011-09-14 | — | — | CN | disclosed |
| CN-102180812-A | New method for industrial production of (2S,3S,5S)-2-amino-3-hydroxyl-5-tert-butyloxycarbonylamino-1,6-diphenyl hexane | JINAN AISI CHEMICAL CO LTD | 2011-09-14 | — | — | CN | disclosed |
| EP-1751125-A1 | RITONAVIR ANALOGOUS COMPOUND USEFUL AS RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF THE RITONAVIR ANALOGOUS COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGOUS COMPOUND. | Cristália Produtos Químicos Farmacêuticos Ltda. (BR) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005111006-A1 | RITONAVIR ANALOGOUS COMPOUND USEFUL AS RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF THE RITONAVIR ANALOGOUS COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGOUS COMPOUND. | Cristália Produtos Químicos Farmacêuticos Ltda. (BR) | 2005-11-24 | — | — | WO | disclosed |
| US-5786500-A | Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane | ABBOTT LABORATORIES (US) | 1998-07-28 | — | — | US | disclosed |
| US-5610193-A | TREATMENT OF AIDS, HIV, IMPROVED ORAL BIOAVAILABILITY | ABBOTT LABORATORIES (US) | 1997-03-11 | — | — | US | disclosed |
| US-5597927-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-01-28 | — | — | US | disclosed |
| EP-0732923-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING HIV PROTEASE INHIBITORS | Abbott Laboratories (US) | 1996-09-25 | — | — | EP | disclosed |
| US-5543552-A | Process for the prepartation of a substituted 2,5-diamino-3-hydroxyhexane | ABBOTT LABORATORIES (US) | 1996-08-06 | — | — | US | disclosed |
| WO-1995020384-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING HIV PROTEASE INHIBITORS | ABBOTT LABORATORIES (US) | 1995-08-03 | — | — | WO | disclosed |